We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-0.67%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$17.5B
AUM Growth
+$1.25B
(+7.7%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
7.69%
Top 10 Holdings %
Top 10 Hldgs %
15.74%
Holding
691
New
246
Increased
140
Reduced
132
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$274M |
| 2 |
Apple
AAPL
|
+$233M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$200M |
| 4 |
Jabil
JBL
|
+$185M |
| 5 |
Zoom
ZM
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$269M |
| 2 |
Oracle
ORCL
|
+$215M |
| 3 |
Estee Lauder
EL
|
+$172M |
| 4 |
Dell
DELL
|
+$160M |
| 5 |
Microsoft
MSFT
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.54% |
| 2 | Consumer Discretionary | 14.14% |
| 3 | Healthcare | 13.6% |
| 4 | Industrials | 12.07% |
| 5 | Financials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
CALL
Cellebrite
CLBT
$3.97B
| $797K | ﹤0.01% |
+66,667
| New | +$745K |
|
477
Adicet Bio
ACET
$75.9M
| $793K | ﹤0.01% |
40,979
| – | – |
|
478
Booz Allen Hamilton
BAH
$9.37B
| $787K | ﹤0.01% |
+5,114
| New | +$767K |
|
479
Pool Corp
POOL
$7.27B
| $772K | ﹤0.01% |
+2,511
| New | +$909K |
|
480
Absci
ABSI
$1.53B
| $770K | ﹤0.01% |
250,000
-100,000
| -29% | -$464K |
|
481
IN8bio
INAB
$9.61M
| $764K | ﹤0.01% |
21,367
+6,500
| +44% | +$209K |
|
482
Kiora Pharmaceuticals
KPRX
$11.4M
| $759K | ﹤0.01% |
180,780
-63,664
| -26% | -$297K |
|
|
DOMA
483
CALL
DELISTED
Doma Holdings, Inc.
DOMA
| $756K | ﹤0.01% |
+124,565
| New | +$749K |
|
|
AEVA
484
CALL
Aeva Technologies
AEVA
$1.65B
| $756K | ﹤0.01% |
+300,000
| New | +$979K |
|
485
CALL
Village Farms International
VFF
$289M
| $755K | ﹤0.01% |
740,000
| – | – |
|
|
VLD
486
CALL
DELISTED
Velo3D, Inc.
VLD
| $734K | ﹤0.01% |
+220,938
| New | +$1.76M |
|
|
GDEV
487
CALL
DELISTED
Nexters Inc. Ordinary Shares
GDEV
| $715K | ﹤0.01% |
+250,000
| New | +$715K |
|
488
Kyverna Therapeutics
KYTX
$480M
| $675K | ﹤0.01% |
90,000
+25,000
| +38% | +$382K |
|
|
GRTS
489
CALL
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $669K | ﹤0.01% |
+1,083,333
| New | +$915K |
|
490
Expedia Group
EXPE
$37.7B
| $662K | ﹤0.01% |
+5,255
| New | +$648K |
|
491
Fractyl Health
GUTS
$107M
| $641K | ﹤0.01% |
150,000
| – | – |
|
492
CALL
Oculis Holding
OCS
$709M
| $598K | ﹤0.01% |
+50,000
| New | +$596K |
|
493
Gain Therapeutics
GANX
$75.5M
| $576K | ﹤0.01% |
+450,000
| New | +$1.17M |
|
494
Werewolf Therapeutics
HOWL
$18.6M
| $575K | ﹤0.01% |
235,705
| – | – |
|
495
TransDigm Group
TDG
$67.6B
| $575K | ﹤0.01% |
450
-226
| -33% | -$290K |
|
496
Cytek Biosciences
CTKB
$606M
| $558K | ﹤0.01% |
100,000
| – | – |
|
|
GAUZ
497
Gauzy
GAUZ
$7.5M
| $554K | ﹤0.01% |
+46,105
| New | +$614K |
|
498
CALL
Taboola.com
TBLA
$1.12B
| $550K | ﹤0.01% |
+160,000
| New | +$646K |
|
499
Tenable Holdings
TENB
$4.04B
| $545K | ﹤0.01% |
+12,512
| New | +$552K |
|
500
Alto Neuroscience
ANRO
$1.1B
| $535K | ﹤0.01% |
50,000
+40,000
| +400% | +$521K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2024 Portfolio in Review
As of Q2 2024, Alyeska Investment Group held 691 positions worth $17.5B, up 7.7% from $16.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Alyeska Investment Group deployed $1.35B of net new capital in Q2 2024, opening 246 new positions and adding to 140 existing holdings. Its largest new stake was Qualcomm: 1,450,565 shares worth $289M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Oracle, an estimated $215M trimmed.
- Alyeska Investment Group's largest Q2 2024 buy was Qualcomm: 1,450,565 shares worth $289M.
- Alyeska Investment Group added most to Zoom in Q2 2024, an estimated $163M increase.
- Alyeska Investment Group's biggest Q2 2024 reduction was Oracle, cutting an estimated $215M.
- Alyeska Investment Group fully exited Alphabet (Google) Class A in Q2 2024, selling an estimated $269M.
- Alyeska Investment Group's ten largest holdings make up 16% of its $17.5B portfolio in Q2 2024.
- Alyeska Investment Group opened 246 new positions and closed 135 in Q2 2024.
- Alyeska Investment Group's portfolio value rose 7.7% quarter-over-quarter to $17.5B.
Based on Alyeska Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.